Login to Your Account

Pharma: Other News To Note

Wednesday, April 17, 2013
• CSL Behring, of King of Prussia, Pa., said European authorities approved an extended use of Berinert, a C1 esterase inhibitor concentrate, for pre-procedure prevention of acute episodes of hereditary angioedema in adult and pediatric patients undergoing medical, dental or surgical procedures.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription